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Objective: The aim of this study is to investigate emotional and behavioral problems among Indonesian patients
with disorders of sex development (DSD) who recently came under clinical management. As diagnostic proce-
dures and treatment had been delayed, patients progressively developed ambiguous bodies, difficult to conceal
from outsiders.
Method: We compared 118 Indonesian patients with DSD aged 6–41 years (60 children, 24 adolescents, 34
adults) and 118 healthy control subjectsmatched for age, gender, and residential settings.We used the Child Be-
havioral Checklist (CBCL), Youth Self-Report (YSR), and Adult Self-Report (ASR) to examine differences between
patient and control groups as well as differences within patients groups.
Results: On the CBCL, parents of young children with DSD reported significantly more emotional and behavioral
problems than parents of matched control. Parents of daughters with CAH reported that their daughters withdrew
themselves from social interactions. On theASR, adultswithDSD reported significantlymore internalizing problems
than controls, particularly anxiety and depression. No other differences in emotional functioningwere found across
different diagnostic groups.
Conclusions: Indonesian patients with DSDwhowere untreated for most of their lives sufferedmore emotional and
behavioral problems than matched controls. Differences and similarities between our findings and observations in
patients fromWestern countries will be discussed.© 2014 Elsevier Inc. All rights reserved.Introduction
Disorders of sex development (DSD) refer to a group of congenital
conditions inwhich the development of chromosomal, gonadal, and an-
atomical sex is atypical [1]. The atypical sex development starts prena-
tally and leads to the development of ambiguous internal and/or
external genitalia, with development of ambiguous secondary sex char-
acteristics (e.g. development of small breasts and facial hair) at puberty.
The large majority of patients are infertile.
The combination of an atypical genital and body appearance and
(suspected) infertility puts patients in a delicate position in society. In
Western countries, patients will be referred for diagnostic procedures
and medical treatment soon after identification of their atypical sex de-
velopment. Diagnostic evaluation will be performed, and patients andCL, Child Behavioral Checklist;
iponegoro University, Jl Prof
./Fax: +62 24 7460051.their parents will be informed about their condition and available treat-
ments. In addition, hospital staff and patient support groups can provide
emotional support and advice with respect to communication about
their condition within their families and communities. Some of the
medical interventions are necessary for survival (e.g. glucocorticoid
and aldosterone replacement in CAH). Among the treatments not nec-
essary for survival are some surgeries directed to correct atypical genital
appearance and prevent atypical pubertal progression. A rationale for
this practice is protection against social stigmatization and providing
optimal opportunities for social participation [2,3]. However, this prac-
tice is currently under debate.
In Indonesia, DSD is largely unknown, even among health practi-
tioners. As a consequence, DSD is often identified late and diagnostic pro-
cedures are postponed or not performed. The large majority of the
patients who presented at our clinic had never undergone diagnostic
evaluation or received medical treatments. Many of these patients lived
with ambiguous genitalia and were developing (adolescents) or had de-
veloped (adults) bodieswith bothmale and female secondary sex charac-
teristics. Some patients doubted their gender as did their parents and
community members. Many patients reported exclusion and other signs
77A. Ediati et al. / Journal of Psychosomatic Research 79 (2015) 76–84of social stigmatization due to their physical appearance. We hypothe-
sized that body ambiguity was stressful and could lead to the develop-
ment of emotional problems. Our study aimed to investigate self-
reported emotional problems in children, adolescents, and adult patients
with DSD in Indonesia.
Method
Study design
In this study, we investigated patient- or parent-reported emotional
and behavioral problems in Indonesian children, adolescents, and adults
with a disorder of sex development (DSD). Findings in patients were
compared to findings in matched control subjects. All patients and par-
ents consulted the DSD team of the Dr. Kariadi Hospital and Faculty of
Medicine of the Diponegoro University (FMDU), Indonesia. The study
protocolwas approved by the board of the ethical committee fromFMDU.
Participants
Patients with DSD
All patients with a proven diagnosis of DSD whowere under clinical
management of the DSD Team of the Dr.Kariadi Hospital and FMDU [4]
were invited for study participation. Patients under age 6, patients with
intellectual disabilities (indicated from parent reports on their child's
academic achievements and/or observed by themedical doctor in inter-
action with the patient), patients with a genital anomaly and features
suggestive of malformation syndromes [5] and patients with sex chro-
mosomeDSDwithoutmosaicismwere excluded for study participation.
We applied these exclusion criteria as a reliable assessment of emotion-
al and behavioral problems is difficult in preschool children and patients
with limited intellectual capacities. Patients with malformation syn-
dromes and Turner syndrome often suffer from additional somatic pa-
thology. Low IQ and intellectual disabilities are more frequently seen
in patients with malformation syndromes and patients with Turner
and Klinefelter syndromes. The additional somatic pathology may also
be related to (other types of) emotional problems. In patients with
Turner and Klinefelter syndromes specific psychopathology is more fre-
quently seen compared to other groups of patients with DSD [6,7]. Of
the 168 patients who matched the inclusion criteria, 21 patients
(12.5%) were lost to follow-up due to relocation or invalid contact de-
tails, and 29 patients (17.3%) declined participation. The response rate
was 70.2%. No specific characteristics were found among parents and
patients who declined participation. Thirty-five adults, 24 adolescents,
23 parents of adolescents and 60 parents of young children filled out
the questionnaires. Table 1 summarizes patients and diagnoses. Details
of the individual clinical data were presented in Appendix A.Table 1
Clinical diagnosis of patients in the study.
DSD diagnosis Age Total
6–11 12–17 18+
Sex chromosome DSD Mosaics 3 0 3 6
46, XY DSD AIS a 5 5 6 16
Gonadal dysgenesis b 9 7 12 28
Hypomasculinization e.c.i. 25 9 7 41
46, XX DSD CAH – SV c 18 2 4 24
Gonadal dysgenesis 0 0 1 1
Cloacal malformation 0 1 1 2
Total 60 24 34 118
Note. CAH-SV= simple virilizing type of congenital adrenal hyperplasia.
a AR gene mutation was confirmed [4].
b A condition in which patients had abnormal hormonal testicular function with
uni/bilaterally undescended testes. The clinical and biochemical presentations
suggest gonadal dysfunction [4].
c CYP 21 mutation was confirmed [4].Control group
For each participating patient, a healthy control subject was found
matched for age, gender, and residential settings. Residential setting
(rural, suburban, or urban area) was chosen as matching criteria in
order to compare subjects living under comparable socioeconomic con-
ditions. Control subjects were approached by local leaders (in Bahasa:
Pak RT or Pak Lurah) ormidwives. After a potentialmatched control sub-
ject was identified, an invitation to join the study was given. In order to
guarantee the privacy of the patients, the Pak RT or Pak Lurah and the
matched control subjects were informed that this study was a popula-
tion study on emotional and behavioral problems carried out at the Fac-
ulty of Psychology, Diponegoro University. None of the potential
matched control subjects declined participation in the study. After the
control subjects gave their written consent to participate in the study,
data collection was conducted following the similar procedure as the
patients with DSD.
Measures
Data on emotional and behavioral problems were obtained using
ASEBA (Achenbach System of Empirically Based Assessment) scales:
the Child Behavior Checklist/CBCL 6–18 [8], the Youth Self-Report/
YSR [8], and the Adult Self-Report/ASR [9]. The ASEBA scales are
widely applied as a screening instrument for psychopathology [8,
9]. Cut-off scores help to identify patients who score in borderline
and clinical ranges and are at risk to develop severe emotional and
behavioral problems. These measures assess behavioral and emo-
tional problems reported over the past six months. Each item is
rated on a 3-point scale: 0 (not true), 1 (somewhat or sometimes
true), and 2 (very true or often true). Higher scores indicate a higher
level of emotional and behavior problems.
CBCL/6–18
The CBCL/6–18 is a 120-item standardized parent-report measure
for emotional and behavioral problems in children aged 6 to 18 years
[8]. It measures on eight scales: Anxious/Depressed, Withdrawn/De-
pressed, Somatic Complaints, Social Problems, Thought Problems, At-
tention Problems, Rule-Breaking Behavior, and Aggressive Behavior.
Thismeasure had been validated across 30 societies and has satisfactory
reliability and psychometric quality for assessing problem behavior in
children across cultures [10]. The validation of the Indonesian version
of the CBCL/6–18 was obtained from a study involving 107 parents of
children aged 6–18 in the Central Java province [11]. The Cronbach's al-
phas found on scales of the Indonesian version of the CBCL/6–18 ranged
between 0.56 (Social problems) and 0.94 (Total Problems) [11]. These
Cronbach's alphas of the Indonesian CBCL/6–18 are comparable to
Cronbach alphas found in other studies [12].
YSR
TheYSR is a 119-item standardized self-reportmeasure for emotion-
al and behavioral problems in youth aged 11 to 18 years [8]. It includes
eight scales similar to the CBCL. The YSR had been validated across 23
countries, and had satisfactory psychometric quality for assessing prob-
lem behavior among adolescents across different cultures [13]. The val-
idation of the Indonesian version of the YSR was obtained from a study
involving 1154 high school students in Central Java province.
Cronbach's alphas of the Indonesian version of the YSR ranged between
0.62 (Social Problems) and 0.92 (Total Problems) [11]. To assess the fac-
tor structure of the Indonesian translation of YSR, we followed proce-
dures for confirmatory factor analysis described by [13] and found
comparable results. The RMSEAof 0.03waswithin the range of previous
report [13] and indicated good fit. The CFI and TLI were 0.86 and 0.85 in-
dicating acceptable fit [13]. The factor loadings ranged from 0.28 to 0.77
with median factor loading 0.57, whereas the factor covariance ranged
from 0.45 to 0.98 with median covariance of 0.73. Thus, the results
78 A. Ediati et al. / Journal of Psychosomatic Research 79 (2015) 76–84confirmed that the eight structure model also holds for the Indonesian
translation of YSR [11].ASR
The ASR is a 131-item standardized self-report measure of emotion-
al and behavioral functioning in adults aged 18 or older [9]. It comprised
eight scales: Anxious/Depressed, Withdrawn, Somatic Complaints,
Thought Problems, Attention Problems, Aggressive Behavior, Rule-
Breaking Behavior, and Intrusiveness. The validity and reliability of the
Indonesian translation of the ASR were assessed following procedures
described by Achenbach and Rescorla [9]. The data was obtained from
a study involving 1091 university students in the Central Java province.
Cronbach's alphas ranged from 0.59 (Thought Problems) to 0.94 (Total
Problems). The RMSEA of 0.02 was within the range of Achenbach and
Rescorla [9] and indicated good fit. The CFI and TLI were both 0.90 indi-
cating a goodfit [10]. The factor loadings ranged from0.17 to 0.78with a
median factor loading of 0.61, whereas the factor covariance ranged
from 0.34 to 0.89 with a median covariance of 0.63. The results con-
firmed that the eight-structure model also holds for the Indonesian
translation of ASR [11].Socio-demographic characteristics
In addition to data on emotional and behavioral problems, we also
collected data on socio-economic status, ethnic and cultural back-
ground, including age, gender, residence, ethnicity, religion, education
(the highest level attained), and occupation.Table 2
On demographic and cultural characteristics.
Characteristics
background
Patients with DSD
(n = 118)
Matched controls
(n = 118)
p-Value
Age of study 13.8 ± 7.4 14.2 ± 7.1 0.69
Region
Central Java province 100 (84.7) 108 (91.5) 0.12
Other provinces in Java 12 (10.2) 9 (7.6)
Outside Java island 6 (5.1) 1 (.8)
Ethnicity
Javanese 108 (91.5) 106 (89.8) 0.82
Non Javanese 10 (8.5) 12 (10.2)Procedures
Data collection was carried out betweenMarch 2007 andMay 2011.
After a DSD was diagnosed [4], patients were invited to participate in
this study. Oral and written study information was provided by a med-
ical doctor (AZJ). After participants had given their informed consent, an
appointment wasmade for the study. For participants under age 18, in-
formed consent was obtained from the parents. The psychological as-
sessment was conducted in the hospital or at home by a trained
psychologist (AE). In participants with limited educational background
(i.e. illiterate) or participants unfamiliar with self-report, ASEBA ques-
tionnaires were administered orally by the psychologist (AE). Similar
to the paper–pencil version, participants had to indicate their response
(0–1–2) for each question, the psychologist ticked off their answer in
the scoring sheet.Religion
Islam 112 (94.9) 108 (91.5) 0.44
Non Islam 6 (5.1) 10 (8.5)
Education—Father* n = 116 n = 114
Illiterate 18 (15.5) 15 (13.2) 0.62
Elementary school 38 (32.8) 31 (27.2)
High school 49 (42.2) 58 (50.9)
University education 11 (9.5) 10 (8.8)
Education—Mother* n = 116 n = 117 0.33
Illiterate 22 (19.0) 14 (12.0)
Elementary school 38 (32.8) 34 (29.1)
High school 48 (41.4) 58 (49.6)
University education 8 (6.9) 11 (9.4)
Occupation—Father* n = 116 n = 114 0.06
Unemployed 6 (5.2) 5 (4.4)
Labor 64 (55.2) 46 (40.4)
Self-employed 19 (16.4) 34 (29.8)
Staff/Office job 27 (23.3) 29 (25.4)
Occupation—Mother* n = 116 n = 117 0.02
Unemployed 57 (49.1) 39 (33.3)
Labor 32 (27.6) 35 (29.9)
Self-employed 12 (10.3) 28 (23.9)
Staff/Office job 15 (12.9) 15 (12.8)
Note. Data presented in n (%), except age: in median (range). Fisher's exact test was
applied; significant at p b 0.05. * indicates differences in n.Statistical analysis
We used the pairedWilcoxon sign-rank test to test for differences
in levels of emotional and behavioral problems between patient and
matched control groups and differences between these groups sepa-
rate for males and females. We also dichotomized the scores on the
ASEBA scales into two categories: individuals scoring above the bor-
derline cut-off point and individuals scoring below the borderline
cut-off point [8,9]. This classification distinguishes between severe
emotional and behavioral problems/psychopathology and problems
in the normal range. With this classification we tested whether there
were differences between age groups and between diagnostic
groups in terms of the number of individuals scoring above the cut-
off point using Fisher's Exact Test. We also used the dichotomized
scores to test differences in the number of individuals scoring
above the cut-off point between patient and matched control groups
in which the age groups were combined. For this analysis we used
the McNemar test. Differences were considered significant at
p b 0.05 (two-sided).Results
Participant characteristics
As shown in Table 2, patients andmatched controls did not differ with respect to their
socio-demographic, ethnic and cultural background. The majority of participants was
male, lived in rural areas, came from the Central Java province, andwas Javanese andMos-
lem. The parents' educational background varied from illiterate to university level, and the
majority had attended high school. Therewas a difference between groupswith respect to
occupation; more parents of patients worked in the lower-income sector or were
unemployed.
Emotional and behavioral problems in patient and control groups
In Table 3, sections A to D, the results on reported emotional and behavioral problems
in patient and control groups are presented.
Children
On the CBCL, parents of children aged 6–11 with DSD reported more emotional and
behavioral problems in their children than parents of the matched control children
(Total Problems: p = 0.02). More specifically parents reported Externalizing Problems
(p=0.03); Social Problems (p=0.04), Attention Problems (p=0.03) andAggressive Be-
havior (p = 0.02). No significant differences were found for the other scales. A separate
analysis by gender revealed that these emotional problems were particularly reported
by parents of boys (Total Problems: p = 0.05; Externalizing Problems p = 0.04 and Ag-
gressive Behavior (p = 0.02). Emotional problems reported by parents of girls with DSD
did not differ from controls (see Table 3A).
Adolescents
No differences on the CBCL and YSR scores were found between the adolescent
patients and the matched control groups (see Table 3B and C).
Adults
As reported in Table 3D, adults with DSD reported more Internalizing Problems than
matched control adults did (p = 0.04); more specifically they reported higher scores on
the Anxious/Depressed scale (p = 0.01). Particularly men with DSD gave higher ratings
on the Anxious/Depressed scale than the matched control men did (p = 0.04), whereas
womenwith DSDmore often reported social isolation compared to theirmatched controls
(p= 0.02).
Table 3
Emotional and behavioral problems reported by parents, adolescents and adults from patient and control groups.
A. Parental report on emotional and behavioral problems in children aged 6–11
CBCL6–18 scalesa Study groups p-Value Boys p-Value Girls p-Value
DSD Controls DSD Controls DSD Controls
n = 60 n = 60 n = 42 n = 42 n = 18 n = 18
Mdn (range) Mdn (range) Mdn (range) Mdn (range) Mdn (range) Mdn (range)
Total problems 23.5 (5–59) 13 (2–69) 0.02 22 (5–59) 13 (2–57) 0.05 25 (9–56) 15.5 (3–69) 0.14
Internalizing problems 4 (0–18) 3 (0–25) 0.45 3 (1–17) 3 (0–25) 0.87 5.5 (1–19) 4 (0–21) 0.48
Externalizing problems 7.5 (0–35) 5 (0–22) 0.03 7.5 (1–31) 5 (0–22) 0.04 6.5 (1–35) 5.5 (0–19) 0.48
Scales:
Anxious/depressed 1 (0–8) 1 (0–10) 0.95 1 (0.18) 1 (0–10) 0.98 1.5 (0–7) 1.5 (0–10) 0.85
Withdrawn/depressed 1.5 (0–12) 1 (0–7) 0.16 1 (0–12) 1 (0–7) 0.67 2 (0–11) 1.5 (0–6) 0.11
Somatic complaints 1 (0–5) 0 (0–8) 0.61 0 (0–4) 0 (0–8) 0.63 1 (0–5) 1 (0–8) 0.89
Social problems 3.5 (0–10) 2 (0–11) 0.04 3 (0–10) 2 (0–11) 0.08 1 (0–8) 4 (1–8) 0.32
Thought problems 1 (0–6) 0 (0–8) 0.91 1 (0–6) 0 (0–7) 0.48 0 (0–4) 0.5 (0–8) 0.38
Attention problems 2 (0–14) 1 (0–11) 0.03 2 (0–14) 1 (0–11) 0.16 3 (0–8) 0.5 (0–11) 0.15
Rule-breaking behavior 2 (0–13) 2 (0–8) 0.23 2 (0–13) 2 (0–8) 0.11 1.5 (0–11) 2 (0–5) 0.70
Aggressive behavior 5.5 (0–24) 3 (0–25) 0.02 5.5 (0–20) 3 (0–18) 0.02 5.5 (1–24) 4.5 (0–14) 0.42
B. Parental report on emotional and behavioral problems in adolescents aged 12–17
CBCL6–18 scalesa Study groups p-Value Boys p-Value Girls p-Value
DSD Controls DSD Controls DSD Controls
n = 23b n = 23 n = 15 n = 15 n = 8 n = 8
Mdn (range) Mdn (range) Mdn (range) Mdn (range) Mdn (range) Mdn (range)
Total problems 9 (4–29) 10 (0–43) 0.40 8 (4–29) 10 (1–43) 0.86 17.5 (5–21) 10.5 (0–21) 0.31
Internalizing problems 3 (0–14) 4 (0–14) 0.59 2 (0–11) 4 (0–14) 0.81 5 (1–14) 3 (0–13) 0.16
Externalizing problems 2 (0–10) 1 (0–12) 0.69 2 (0–10) 1 (0–12) 0.93 1 (0–8) 2.5 (0–6) 0.57
Scales:
Anxious/depressed 1 (0–4) 1 (0–5) 0.73 1 (0–4) 1 (0–5) 0.66 1 (0–2) 0.5 (0–3) 0.91
Withdrawn/depressed 2 (0–11) 1 (0–10) 0.68 1 (0–7) 2 (0–6) 0.55 3 (0–11) 1 (0–10) 0.19
Somatic complaints 0 (0–6) 1 (0–7) 0.60 0 (0–3) 0 (0–7) 0.95 1.5 (0–6) 0.5 (0–4) 0.41
Social problems 2 (0–7) 1 (0–7) 0.63 2 (0–7) 1 (0–7) 0.52 2 (0–5) 1.5 (0–5) 0.99
Thought problems 0 (0–3) 0 (0–4) 0.99 0 (0–3) 0 (0–4) 0.78 0.5 (0–2) 0 (0–2) 0.81
Attention problems 2 (0–6) 1 (0–6) 0.99 1 (0–5) 1 (0–5) 0.40 2.5 (0–6) 0.5 (0–6) 0.37
Rule-breaking behavior 0 (0–5) 0 (0–4) 0.36 0 (0–5) 1 (0–4) 0.51 0.5 (0–2) 0 (0–3) 0.75
Aggressive behavior 1 (0–8) 1 (0–8) 0.82 1 (0–8) 1 (0–8) 0.99 0.5 (0–7) 1.5 (0–4) 0.80
C. Self-report on emotional and behavioral problems in adolescents aged 12–17
YSR 12–17 scalesa Study groups p-Value Boys p-Value Girls p-Value
DSD Controls DSD Controls DSD Controls
n = 24 n = 24 n = 15 n = 15 n = 9 n = 9
Mdn (range) Mdn (range) Mdn (range) Mdn (range) Mdn (range) Mdn (range)
Total problems 18.5 (3–65) 18.5 (0–107) 0.86 14 (3–52) 19 (0–50) 0.57 28 (7–60) 18 (3–96) 0.50
Internalizing problems 5 (0–25) 5.5 (0–35) 0.51 3 (0–25) 6 (0–16) 0.27 11 (1–25) 5 (0–35) 0.12
Externalizing problems 5 (0–14) 5.5 (0–22) 0.38 3 (1–16) 6 (0–15) 0.53 6 (0–21) 5 (1–21) 0.89
Scales:
Anxious/depressed 1.5 (0–10) 2 (0–19) 0.55 1 (0–7) 2 (0–9) 0.62 3 (1–10) 2 (0–19) 0.38
Withdrawn/depressed 2 (0–13) 2.5 (0–9) 0.60 1 (0–11) 3 (0–5) 0.24 7 (0–13) 2 (0–9) 0.20
Somatic complaints 1 (0–9) 0 (0–7) 0.46 1 (0–7) 0 (0–6) 0.99 1 (0–9) 0 (0–7) 0.30
Social problems 2.5 (0–10) 3 (0–14) 0.99 2 (1–10) 3 (0–6) 0.99 3 (0–6) 2 (1–14) 0.87
Thought problems 0 (0–6) 0 (0–10) 0.85 0 (0–6) 1 (0–4) 0.99 0 (0–4) 0 (0–10) 0.99
Attention problems 2.5 (0–13) 3.5 (0–15) 0.99 2 (0–9) 3 (0–8) 0.68 5 (0–13) 5 (0–15) 0.73
Rule-breaking behavior 1 (0–10) 2 (0–7) 0.36 1 (0–10) 2 (0–7) 0.34 1 (0–8) 1 (0–6) 0.79
Aggressive behavior 3 (0–13) 3 (0–16) 0.52 2 (0–13) 3 (0–13) 0.53 5 (0–9) 5 (0–16) 0.81
D. Adult self-report on emotional and behavioral problems (aged 18–41)
ASR 18 + scalesa Study groups p-Value Men p-Value Women p-Value
DSD Controls DSD Controls DSD Controls
n = 34 n = 34 n = 20 n = 20 n = 14 n = 14
Mdn (range) Mdn (range) Mdn (range) Mdn (range) Mdn (range) Mdn (range)
Total problems 40.5 (3–138) 32.5 (2–116) 0.40 28.5 (3–80) 25.5 (2–106) 0.53 64.5 (12–178) 53.5 (5–116) 0.24
Internalizing problems 15.5 (0–59) 10.5 (0–51) 0.04 11.5 (0–41) 7.5 (1–38) 0.15 25 (7–59) 15 (3–51) 0.15
Externalizing problems 8 (1–36) 8 (0–25) 0.65 6 (1–22) 5.5 (0–24) 0.60 11 (1–36) 14 (0–25) 0.98
Scales:
Anxious/depressed 9 (0–34) 5 (0–26) 0.01 6.5 (0–23) 2.5 (0–16) 0.04 14 (0–25) 14 (5–34) 0.18
Withdrawn 4 (0–16) 2.5 (0.10) 0.07 2.5 (0–2) 2 (0–9) 0.69 6 (1–16) 3.5 (0–10) 0.02
Somatic complaints 1.5 (0–16) 2 (0–17) 0.51 1 (0–8) 1 (0–13) 0.84 3 (0–16) 3 (0–16) 0.60
Thought problems 2 (0–8) 2 (0–9) 0.54 1 (0–5) 1 (0–9) 0.73 2 (0–8) 4 (0–6) 0.81
(continued on next page)
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Table 3 (continued)
D. Adult self-report on emotional and behavioral problems (aged 18–41)
ASR 18 + scalesa Study groups p-Value Men p-Value Women p-Value
DSD Controls DSD Controls DSD Controls
n = 34 n = 34 n = 20 n = 20 n = 14 n = 14
Mdn (range) Mdn (range) Mdn (range) Mdn (range) Mdn (range) Mdn (range)
Attention problems 4 (0–21) 5.5 (0–19) 0.33 3 (0–16) 3.5 (0–16) 0.60 7 (0–21) 6.5 (0–19) 0.40
Aggressive behavior 6 (0–21) 5 (0–15) 0.39 4 (1–16) 7.5 (0–21) 0.15 7.5 (0–21) 9 (0–15) 0.77
Rule-breaking behavior 1 (0–12) 1.5 (0–7) 0.94 1 (0–6) 1.5 (0–7) 0.45 1 (0–12) 1.5 (0–5) 0.30
Intrusive 1 (0–9) 1 (0–7) 0.87 1 (0–4) 1 (0–7) 0.76 1 (0–9) 1.5 (0–7) 0.89
Note. The paired Wilcoxon signed-rank test has been applied.
a Higher scores indicate more problems.
b One parent did not complete the CBCL; data were excluded from analysis. The child completed the YSR; these data were included.
80 A. Ediati et al. / Journal of Psychosomatic Research 79 (2015) 76–84Analyses in specific patient and control groups
Are there differences in emotional and behavioral problems between patients from
different age groups? Table 4 shows that Internalizing problems, more specifically
Anxiety/Depression and Thought Problems, were more prominent among adult pa-
tients whereas Externalizing problems were more frequently reported in children.
Similar analysis in the matched control group revealed no significant differences
across age groups on all scales.
Are behavioral and emotional problemsmore frequently reported by patients from specific
diagnostic groups? Comparison of patients between diagnostic groups did not reveal any
significant differences.
Do patients with DSD more often suffer from psychopathology than matched controls? In
order to identify patients and controls with severe emotional and behavioral problems
and psychopathology, we dichotomized the scale scores into two categories: below or
above the cut off point for borderline-clinical ranges [8,9]. Statistical analyses revealed
no significant differences between patient and control groups on any of the scales. This
means that there were no differences between patients and controls regarding the num-
ber of individuals suffering severe psychopathology.
Do patientswho never receivedmedical treatments reportmore emotional and behavioral
problems compared to patients who had received medical treatments? Again, analyses were
performed in data split up in scale scores below and above the cut-off point. It was found
that patients who had never received medical treatments reported more internalizing
problems than patients who had been under clinical management (29.8% versus 19.7%;
p = 0.047).
Do patients who changed gender experienced more emotional and behavioral problems
compared to patients who had not? In another study described elsewhere [14] we observed
large numbers of children, adolescents and adults who had changed gender. Analyses per-
formed for scale scores below/above the cut-off point did not reveal any differences be-
tween these patient groups, meaning that psychopathology was observed equally among
patients whohad changed gender andpatients who had kept the gender allocated at birth.Discussion
This study aims to investigate emotional and behavioral problems in
Indonesian patients with DSD. Due to unfamiliarity with DSD, many of
these patients came under medical attention late and had lived forTable 4
Comparison among children, adolescents, and adults with DSDswho are scored above cut
points across age groups.
Scales Children
(n = 60)
Adolescents
(n = 24)
Adults
(n = 34)
p-Value
Total problems 11 (18.3) 3 (12.5) 7 (20.6) 0.73
Internalizing problems 9 (15.0) 4 (16.7) 16 (47.1) 0.003*
Externalizing problems 14 (23.3) 0 5 (14.6) 0.02*
Scales:
Anxious/depressed 1 (1.7) 0 10 (29.4) b0.001**
Withdrawn/depressed 11 (18.3) 3 (12.5) 11 (32.4) 0.16
Somatic complaints 1 (1.7) 3 (12.5) 4 (11.8) 0.20
Social problems a 7 (11.7) 2 (8.3) – 0.99
Thought problems 1 (1.7) 0 4 (11.8) 0.046*
Attention problems 3 (5.0) 1 (4.2) 5 (14.7) 0.24
Rule-breaking behavior 5 (8.3) 1 (4.2) 1 (2.9) 0.59
Aggressive behavior 10 (16.7) 1 (4.2) 3 (8.8) 0.26
Intrusive b – – 1 (2.9) –
Note. Data presented in n (%). The Fisher Exact test was applied; significant at p b 0.05.
a n = 84. The social problem scale was only available in the CBCL and YSR.
b n = 34. The intrusive scale was only available in the ASR.many years with an ambiguous body appearance. We hypothesized
that lack of knowledge on the diagnosis, the atypical appearance of
the body and reactions from the community could lead to emotional in-
stability and would have repercussions on behavior. In this study, par-
ents reported more emotional and behavioral problems in their
children than parents of control children did. Parents reported social
problems, attention problems, and, particularly in boys, aggressive be-
haviors and externalizing problems. Adult patients, men in particular,
reported anxiety and had elevated scores on the internalizing problems
scale. Women were more likely to report social isolation. They did not
report anxiety, but the number of women participating in this study
was smaller than the number of men and non-significant differences
found in this group may be explained by insufficient sample sizes. No
specific emotional and behavioral problems were reported by adoles-
cent patients and their parents. The adolescent group was smaller
than the other age groups and the small group size may explain lack
of differences between adolescent patients and their control subjects.
Parents of young girls with CAH indicated that their daughters tended
to withdraw themselves from social activities. Although patients with
DSD reported more emotional and behavioral problems than controls,
severe psychopathology was not observed more frequently in the pa-
tient groups.
Parents of young boyswith DSD reportedmore aggressive behaviors
and more overall externalizing problems than parents of their matched
control boys did, whereas such differences were not found among
young girls. In Chinese patients with DSD, Zhu et al. [16] observed that
boys with DSD displayed more depression than the control boys did.
We observed higher reports of depression too, but only in adult men
with DSD. Thesemen also reportedmore anxiety. Compared to controls,
womenwithDSDwithdrew themselvesmore frequently from social ac-
tivities. Living a withdrawn life is often associated with depression. De-
pressive complaints were also observed by Migeon et al. in American
men and women with 46, XY DSD [17]. Unfortunately, we could not
compare our findings on adult patients with general population of
Indonesia due to lack of published data.
Emotional and behavioral problems in patients with DSD have been
assessed before by Kleinemeier et al. [15]. They did not find differences
between patient and normative groups. The patients participating in
these studies had been under clinicalmanagement soon after identifica-
tion of their DSD. Our findings in Indonesian patients therefore may be
an indication that early diagnostic evaluation, information on the disor-
der and medical treatment may prevent the development of emotional
problems.
This study is unique; for a long time patients had lived with a lack of
knowledge about their condition and without sufficient medical help.
Almost half of the patients (48%) never had received any information
about their DSD condition nor had received medical or surgical treat-
ments prior to the study. The remaining52% of thepatients had received
some treatment, but almost all patients never received complete medi-
cal care. Often patients could not afford surgery or medication, or med-
ication was not available regularly. All patients had to live with
81A. Ediati et al. / Journal of Psychosomatic Research 79 (2015) 76–84ambiguous genitalia and/or an ambiguous body appearance following
puberty.We assume it is difficult to copewith these ambiguities, partic-
ularly when such conditions are not understood. For some of the pa-
tients it is difficult to cope, and difficulties in coping may lead to the
development of emotional problems such as depression and anxiety.
The findings in this study are in line with previous findings in a study
on sexuality; women with DSD reported sexual distress, fear of rejec-
tion, and avoidance to enter romantic relationships [18].
Our findings underline that it is important that patients with DSD
will be referred immediately after identification of their condition to a
specialized, multidisciplinary teams. These teams should not only offer
diagnostic evaluation and medical treatment, but also education and
counseling. These conditions are congenital and cannot be cured. In
non-Western countries, for many patients, complete clinical manage-
ment is not available or is too expensive. As patients have to live with
DSD for a lifetime, it is important that they understand their condition
and can communicate about it with their family members and/or
othermembers of their communities. Such communication can improve
understanding and acceptance and support.
In conclusion, we identified emotional instability among Indonesian
patients with DSD who were identified late in life. Internalizing prob-
lems were evident among patients. Early identification of DSD and
early referral to a specialized center for clinical management may con-
tribute in understanding the condition, enhances coping abilities, and
improves patients' wellbeing and therefore should be promoted
among health practitioners in Indonesian primary care centers.
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and submission.Appendix A. Characteristics of patients with DSD: diagnoses, reported treatment received, and gender development history (n = 118).Patients
codeAge at
studyDiagnosis Degree of masculinization at admission Treatment received prior to studyAge Phallus f EMS g P/Q h GenderChildren (01–60)
01 6 46,XX DSD CAH-SV a 3 2.8 6 3 F None
02 6 46,XX DSD CAH-SV a 3 4.5 4 4 F Hydrocortisone since age 3.
03 6 46,XX DSD CAH-SV a 6 4 4 4 F Clitoridoplasty age 6; hydrocortisone since age 6.
04 6 46,XX DSD CAH-SV a 4 4 7 4 F Hydrocortisone since infancy; clitoridoplasty age 5.
05 6 46,XX DSD CAH-SV a 6 4.5 4 4 F Hydrocortisone since age 4 (other clinic).
06 7 46,XX DSD CAH-SV a 2 months 2.5 4 4 F Hydrocortisone since age 3.
07 8 46,XX DSD CAH-SV a 4 4.1 4 4 F Medication at birth (other clinic; details unknown);
clitoridectomy age 5.
08 8 46,XX DSD CAH-SV a 2 3 4 3 F Hydrocortisone since age 1; clitoridectomy age 2.
09 8 46,XX DSD CAH-SV a 8 4.3 4 4 F None
10 8 46,XX DSD CAH-SV a 8 6 4 5 M Hydrocortisone irregularly since infancy.
11 8 46,XX DSD CAH-SV a 8 5.5 3 3 M None
12 9 46,XX DSD CAH-SV a 7 4.5 4 4 F None
13 10 46,XX DSD CAH-SV a 6 4.5 4 3 F Hydrocostisone irregularly at infancy; regularly
since age 4; clitoridoplasty age 7.
14 11 46,XX DSD CAH-SV a 7 5 4 4 F None
15 11 46,XX DSD CAH-SV a 11 3 7 4 F Clitoridectomy age 2; hydrocortisone since age 11.
16 11 46,XX DSD CAH-SV a 11 Normal clitoris 1 3 F None
17 11 46,XX DSD CAH-SV a 11 Normal clitoris 4 2 F Clitoridectomy age 4 (other clinic).
18 11 46,XX DSD CAH-SV a 11 3.5 4 3 F Clitoridoplasty age 8 (other clinic) and 11;
hydrocortisone age 11.
19 7 Chromosomal DSD 46,XX/47,XY 1 3 9 4 M None
20 7 Chromosomal DSD 46,XX/47,XY 7 3 8.5 4 M None
21 9 Chromosomal DSD 46,XY/46,XX 4 3.5 6 2 M Orchidectomy age 4; HCG injection age 5(continued on next page)
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codeAge at
studyDiagnosis Degree of masculinization at admission Treatment received prior to studyAge Phallus f EMS g P/Q h Gender22 6 Chromosomal DSD 46,XY/45,X c 2 1.5 6 2 M Surgery once (details unknown)
23 7 Chromosomal DSD 46,XY/45,X 2 1.7 1 4 F Vaginoplasty, orchidectomy age 4
24 9 Chromosomal DSD 46,XY/45,X 9 4 5 3 M None
25 6 46,XY DSD GD b 2 2 5 2 M None
26 6 46,XY DSD GD b 5 3 5 3 M Chordaectomy age 5; urethroplasty age 6
27 7 46,XY DSD GD b 3 3 9 3 M Surgery age 2 (details unknown; other clinic)
28 8 46,XY DSD GD b 7 3.5 3 3 F None
29 10 46,XY DSD GD b 10 Normal clitoris 1 6 F None
30 11 46,XY DSD GD b 10 4.5 6 2–3 M None
31 6 46,XY DSD PAIS c 2 2 6 2 M Surgery (details unknown)
32 6 46,XY DSD PAIS c 5 2.5 7 3 M HCG injection age 5
33 10 46,XY DSD PAIS c 4 4.9 10 2 M None
34 10 46,XY DSD PAIS c 10 4.5 6.5 4 M None
35 11 46,XY DSD PAIS c 11 4.5 6 3 M None
36 6 46,XY DSD Hypomasculinization d 1 2 6 3 M Hypospadia correction twice, urethroplasty age 2
37 6 46,XY DSD Hypomasculinization d 3 2 6 3 M Hypospadia corrections three times
(details unknown)
Children (01–60)
38 6 46,XY DSD Hypomasculinization d 4 3 5 2 M Chordaectomy, orchidopexy age 4;
urethroplasty age 5
39 6 46,XY DSD Hypomasculinization d 6 3 6 3 M None
40 7 46,XY DSD Hypomasculinization d 2 3.7 5.5 4 F None
41 8 46,XY DSD Hypomasculinization d 7 3 4 2 M None
42 8 46,XY DSD Hypomasculinization d 3 3 6 2 M Chordaectomy age 2; urethroplasty
age 3 and 4 (other clinic)
43 9 46,XY DSD Hypomasculinization d 9 3 6 3 M None
44 10 46,XY DSD Hypomasculinization d 7 2 6 3 M Urethroplasty, chordaectomy, age 7 and 10
45 10 46,XY DSD Hypomasculinization d 8 2.5 6 3 M Surgery age 9 and 10 (details unknown)
46 11 46,XY DSD Hypomasculinization d 7 3 6 3 M Orchidopexy age 7
47 11 46,XY DSD Hypomasculinization d 11 3.5 6 4 M None
48 11 46,XY DSD Hypomasculinization d 11 4 6 3 M None
49 6 46,XY DSD Hypomasculinization d 2 4 9 3 M Surgery twice
(details unknown; other clinic)
50 6 46,XY DSD Hypomasculinization d 5 3 9 3 M Chordaectomy, urethroplasty age 5
51 6 46,XY DSD Hypomasculinization d 6 2.4 9 2 M None
52 7 46,XY DSD Hypomasculinization d 7 3 9 2 M None
53 8 46,XY DSD Hypomasculinization d 3 3 10 2 M None
54 9 46,XY DSD Hypomasculinization d 4 2.5 9 3 M Hypospadia correction age 6
55 9 46,XY DSD Hypomasculinization d 6 3 9 2 M None
56 9 46,XY DSD Hypomasculinization d 6 3
(low position)
10 3 M Surgery age 6, 7, 8 (details unknown)57 9 46,XY DSD Hypomasculinization d 9 2.7 10 3 M None
58 9 46,XY DSD Hypomasculinization d 8 3.5 9 3 M None
59 10 46,XY DSD Hypomasculinization d 7 4 9 3 M Hypospadia correction age 4, 6, 7
60 10 46,XY DSD Hypomasculinization d 9 3.5 9 3 M Chordaectomy age 9.Adolescents (61–84)
61 12 46,XX DSD CAH-SV a 12 Normal clitoris 1 3 F Clitoridectomy age 3 (other clinic).
62 16 46,XX DSD CAH-SV a 16 Normal clitoris 1 2 F Clitoridectomy age 7 (other clinic).
63 13 46,XX DSD Cloacal
mal-formation e
12 1.9 1 0 F Colostomy repair one day after birth.64 13 Chromosomal DSD 46,XY/45,X 12 3 8 2 M Hypospadia correction,
gonadectomy age 12.65 14 Chromosomal DSD 46,XY/45,X 10 3.2 10 1 M None
66 14 Chromosomal DSD 46,XY/45,X 13 4 8 2 M Chordectomy age 13.
67 13 46,XY DSD GD b 12 4.1 8 3 F None
68 15 46,XY GD b 15 6.5 8 2 M None
69 17 46,XY DSD GD b 13 Normal clitoris 1 6 F Gonadectomy age 10 (other clinic);
estrogen supplement since age 13.
70 17 46,XY DSD GD b 17 5 4 4 F None
71 16 46,XY DSD CAIS c 16 Normal clitoris 1 6 F None
72 12 46,XY DSD PAIS c 5 1.5 7 4 M None
73 12 46,XY DSD PAIS c 9 3 5 3 F None
74 13 46,XY DSD PAIS c 12 3.1 6 3 M None
75 15 46,XY DSD PAIS c 12 3.1 6 5 M Testosterone injection, gynecomastia
age 13; hydrocele surgery age 14
76 12 46,XY DSD Hypomasculinization d 12 5 6 3 M None
77 13 46,XY DSD Hypomasculinization d 13 5 6 3 M Chordectomy age 5, 6
78 14 46,XY DSD Hypomasculinization d 14 3.2 7 3 M Surgery age 4 (details unknown);
chordectomy, urethroplasty age 14
79 14 46,XY DSD Hypomasculinization d 10 3 5 2 M Urethroplasty age 8
80 17 46,XY DSD Hypomasculinization d 12 7.1 6,5 3 F None
81 17 46,XY DSD Hypomasculinization d 14 6.5 6 2 M Hypospadia correction age 15
82 13 46,XY DSD Hypomasculinization d 8 4 9 2 M Surgery (details unknown)
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sculinization in 46, XX (Prader) and 46, XY (Quigley) indivTreatment received prior to studyAge Phallus f EMS g P/Q h Gender83 14 46,XY DSD Hypomasculinizationd 9 5.2 9 2 M Chordectomy, hypospadia correction
age 10 and 1184 15 46,XY DSD Hypomasculinizationd 14 5 9 2 M Chordectomy age 14,
urethroplasty age 15Adults (85–118)
85 18 46,XX DSD CAH-SV a 11 3.6 4 3 F Clitoridectomy age 16; Hydrocortisone
86 22 46,XX DSD CAH-SV a 17 7 4 5 M None
87 24 46,XX DSD CAH-SV a 24 5 7 5 M None
88 36 46,XX DSD CAH-SV a 33 3.6 4 3 F Clitoral reduction age 34;
prednisone since age 36.
89 22 46,XX DSD Cloacal malformatione 15 3.5 4 2 M None
90 18 46,XX DSD GD b 10 3.2 6 4 M Treatment in other clinic (unknown),
in infancy and age 7
91 18 Chromosomal DSD 46,XX/45,X 18 Normal clitoris 1 0 F None
92 20 Chromosomal DSD 46,XX/45,X 20 Normal clitoris 1 0 F Pills (unknown; to get menstruation)
age 20; Dianne35 pills
Adults (85–118)
93 29 Chromosomal DSD 45,X/46,XX 25 Normal clitoris 1 0 F Cycloprogynova age 23; Profertil,
Zumenon age 30
94 19 Chromosomal DSD 46,XY/45,X 19 5.5 6 3 F None
95 20 Chromosomal DSD 46,XY/45,X 20 6 4 3 F None
96 19 46,XY DSD GD b 14 4.1 4 3 F Gonadectomy age 14
97 19 46,XY DSD GD b 19 Normal clitoris 2 6 F None
98 19 46,XY DSD GD b 19 5 8 3 F None
99 21 46,XY DSD GD b 14 6 5 2 F None
100 21 46,XY DSD GD b 21 5 4 3 F Chordectomy age 11
101 23 46,XY DSD GD b 23 Normal clitoris 1 7 F None
102 27 46,XY DSD GD b 27 5 4.5 3 F None
103 27 46,XY DSD GD b 26 2.5 3 4 M None
104 39 46,XY DSD GD b 39 1 5 5 F None
105 41 46,XY DSD GD b 41 3 6 4 M None
106 24 46,XY DSD CAIS c 24 Normal clitoris 1 6 F None
107 18 46,XY DSD PAIS c 11 3 5 3 M None
108 18 46,XY DSD PAIS c 15 6.3 7 3 M Chordectomy age 15; urethroplasty age 16
109 20 46,XY DSD PAIS c 16 3.7 9 2 M Gynecomasty, chordectomy, hypospadia
corrections age 14 and 15
110 27 46,XY DSD PAIS c 27 4.5 6 4 F None
111 31 46,XY DSD PAIS c 26 2.6 6 3 F Gynecomasty, chordee correction age 24;
hypospadia correction age 26.
112 19 46,XY DSD Hypomasculinization d 14 5.3 7 2 M Chordectomy age 15; urethroplasty age 19.
113 22 46,XY DSD Hypomasculinization d 17 1.5 3 3 F None
114 26 46,XY DSD Hypomasculinization d 23 5.9 5 3 F Gynecomasty, chordectomy, hypospadia
correction age 23.
115 20 46,XY DSD Hypomasculinization d 15 6 11 2 M Hypospadia correction age 5.
116 20 46,XY DSD Hypomasculinization d 15 6.5 9 3 M Penis bend (twice), hypospadia
corrections age 13, 15, and 16.
117 23 46,XY DSD Hypomasculinization d 23 6 9 2–3 M None
118 28 46,XY DSD Hypomasculinization d 28 6 9 2–3 M Chordectomy age 22 (other clinic)..
ndescended testes. The clinical and biochemical presen-
described in other publication elsewhere [4]
iduals [19,20].References
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